Webinar recording “Efficient Patient Identification in ALS Clinical Trials” now available

Two weeks ago, we presented the free webinar: "Efficient Patient Identification in…

Words Lucie van Leeuwen.Published November 24, 2020
Webinar recording “Efficient Patient Identification in ALS Clinical Trials” now available

Two weeks ago, we presented the free webinar: “Efficient Patient Identification in ALS Clinical Trials; Leveraging the Concept of Fast and Slow Progressors.” This was done in collaboration with Julius Clinical. Over 70 people registered to attend the webinar and we would like to thank everyone for their interest. We also have good news for anyone who missed the webinar or would like to watch it again. The video recording is now available for your viewing, and can be accessed below.

During this webinar, Prof. Dr. Leonard Van Den Berg and Dr. Ruben van Eijk (UMC Utrecht, the Netherlands) provided their insights on:

> Prediction-based inclusion criteria
> Defining the concept of fast vs slow progressors
> Addressing disease heterogeneity and reduce variance
> Regulatory perspective (EMA) on prediction-based patient selection

If you would like to learn more about the prediction model discussed in our webinar, discuss your trial design with the TRICALS team or if you have any other questions, please contact us at info@tricals.org.

Click on the button below to watch the webinar (starts at 06:56)

Watch Webinar

 


Share

Related news

The Lalji Family ALS Award
The Lalji Family ALS Award
The Lalji Family ALS Award is a global prize celebrating excellence in […]
More patients eligible for treatment research through innovative study design
More patients eligible for treatment research through innovative study design
Due to a new trial design for treatment research, more ALS patients […]
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Today, Amylyx Pharmaceuticals provided an update on its plans to advance its […]
Retrotope announces initiation of RT001 study in people with ALS
Retrotope announces initiation of RT001 study in people with ALS
Retrotope Inc has announced that the first participants have been enrolled in […]